ConductScience.org, home

Paper42015103

SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study.

Lin X and 8 others. BMC Cancer, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study. Papers, record 42015103. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42015103

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
SARS-CoV-2 infection and its effects on toxicity and survival in non-metastatic nasopharyngeal carcinoma: a matched cohort study.
PubMed
Journal
BMC Cancer
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin XXiaoping
2Mo FFei
3Zhang BBin
4Pan YYufei
5Dai JJinxuan
6Liao SShufang
7Mo YYunyan
8Kong XXiangyun
9Jiang WWei

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Nasopharyngeal CarcinomaMajor topic
COVID-19Major topic
Nasopharyngeal NeoplasmsMajor topic
ChemoradiotherapyMajor topic
Humans
Female
Male
Retrospective Studies
Middle Aged
Adult
SARS-CoV-2
Aged

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
AB24010078the Key Research and Development Program of GuangxiPubMed
20230127-1the Science Research and Technology Development Program of GuilinPubMed

Source PubMed

Download CSV of grants

References36

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130705369A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold.Sci Rep2019https://conductscience.org/library/papers/30705369PubMed
233783535Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy.J Radiat Res2021https://conductscience.org/library/papers/33783535PubMed
324231245Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.Radiother Oncol2014https://conductscience.org/library/papers/24231245PubMed
426784176Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization.Int J Mol Sci2016https://conductscience.org/library/papers/26784176PubMed
532479790Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study.Lancet Oncol2020https://conductscience.org/library/papers/32479790PubMed
632286310Sex-associated molecular differences for cancer immunotherapy.Nat Commun2020https://conductscience.org/library/papers/32286310PubMed
732479787Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.Lancet Oncol2020https://conductscience.org/library/papers/32479787PubMed
832302681Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement.Int J Radiat Oncol Biol Phys2020https://conductscience.org/library/papers/32302681PubMed
939214285COVID-19-related liver injury: Mechanisms, diagnosis, management; its impact on pre-existing conditions, cancer and liver transplant: A comprehensive review.Life Sci2024https://conductscience.org/library/papers/39214285PubMed
1037993681Mechanisms and consequences of sex differences in immune responses.Nat Rev Nephrol2024https://conductscience.org/library/papers/37993681PubMed
1127686945
Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.
Lancet Oncol2016https://conductscience.org/library/papers/27686945PubMed
1229140166Inactivation of a Single Eucaryotic Gene Irradiated in Vitro in Transcriptionally Active Chromatin Form.Radiat Res1986https://conductscience.org/library/papers/29140166PubMed
1338463154Assessing the impact of interventions on the major Omicron BA.2 outbreak in spring 2022 in Shanghai.Infect Dis Model2024https://conductscience.org/library/papers/38463154PubMed
1432224151Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.Ann Oncol2020https://conductscience.org/library/papers/32224151PubMed
1529718841Radiotherapy alone and with concurrent chemotherapy for nasopharyngeal carcinoma: A retrospective study.Medicine (Baltimore)2018https://conductscience.org/library/papers/29718841PubMed
1635507598Characterizing cancer and COVID-19 outcomes using electronic health records.PLoS One2022https://conductscience.org/library/papers/35507598PubMed
1733275517Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones.Am J Physiol Heart Circ Physiol2021https://conductscience.org/library/papers/33275517PubMed
1828728794Myeloid suppressor cells in cancer and autoimmunity.J Autoimmun2017https://conductscience.org/library/papers/28728794PubMed
1932745693Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.Ann Oncol2020https://conductscience.org/library/papers/32745693PubMed
2033538338Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin2021https://conductscience.org/library/papers/33538338PubMed

See all 36 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42015103

GET https://conductscience.org/api/papers/v1/42015103/references?page=2